Abirtega™ (abiraterone acetate tablets – CivicaScript) — Cigna
Prostate Cancer – Regional Risk Group
Initial criteria
- Patient age ≥ 18 years
- Medication is used in combination with prednisone
- Patient has regional lymph node metastases and no distant metastases
- Patient meets ONE of the following: (i) Medication is concurrently used with a GnRH analog OR (ii) Patient has had a bilateral orchiectomy
Approval duration
1 year